Glikirovannyy gemoglobin - osnovnoy parametr v kontrole sakharnogo diabeta
https://doi.org/10.14341/2072-0351-5588
Abstract
About the Authors
Inna Vladimirovna MisnikovaAlexander Vasil'evich Dreval'
Yulia Alexandrovna Kovaleva
References
1. Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. N Engl J Med 329:978-986, 1993.
2. DCCT Research Group: The association between glycaemic exposure and long-term diabetic complications in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995[Medline].
3. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1988.
4. American Diabetes Association: Standards of medical care in diabetes- 2008. Diabetes Care 2008;31(Suppl):S12-S54.
5. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):4-68.
6. IDF Clinical Guidelines Task Force: Global Guidelines for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
7. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes: ESC/EASD Pocket Guidelines. 2007.
8. ACCORD study Group. Effects of Intensive Glucose Lowering in type 2 Diabetes. N Engl J Med 2008;358:2545-2559.
9. The ADVANCE collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 Diabetes. N Engl J Med 2008;358:2560-2572.
10. Koro CE, et al. Diabetes Care 2004; 27:17-20 Liebl A. Diabetologia; 2002; 45:S23-S28.
11. Liebl A. Diabetologia 2002; 45:S23-S28
12. Ильин А.В. Уровень гликированного гемоглобина - ключевой параметр контроля в лечении сахарного диабета и профилактике его осложнений. Лаборатория. №1, 2008.
13. Nathan D M., KuenenJ, Borg R, Zheng H, , Schoenfeld D, Heine R Translating the A1C Assay Into Estimated Average Glucose Values Diabetes Care 31:1473-1478, 2008.
Review
For citations:
Misnikova I.V., Dreval' A.V., Kovaleva Yu.A. Glikirovannyy gemoglobin - osnovnoy parametr v kontrole sakharnogo diabeta. Diabetes mellitus. 2008;11(4):38-40. https://doi.org/10.14341/2072-0351-5588
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
